Principal Financial Group Inc Concert Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $144,506 - $207,703	-12,845 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $3,192 - $4,452	249 Added 1.98%	12,845 $191,000
Q2 2018 Aug 13, 2018	BUY	$16.83 - $21.66 $211,990 - $272,829	12,596 New	12,596 $0
Q4 2017 Feb 13, 2018	SELL	$13.96 - $29.05 $1.66 Million - $3.45 Million	-118,600 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$13.91 - $15.31 $1.65 Million - $1.82 Million	118,600	118,600 $1.75 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.